TY  - GEN
AU  - Colozza,M
AU  - Mosconi,A M
AU  - Gori,S
AU  - Belsanti,V
AU  - Basurto,C
AU  - De Angelis,V
AU  - Giansanti,M
AU  - Tonato,M
TI  - Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide
SN  - 0277-3732
PY  - 1997///1119
KW  - Adult
KW  - Aged
KW  - Analysis of Variance
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Antineoplastic Agents, Alkylating
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Ascites
KW  - pathology
KW  - Carcinoma
KW  - drug therapy
KW  - Cisplatin
KW  - Confidence Intervals
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Forecasting
KW  - Humans
KW  - Laparotomy
KW  - Longitudinal Studies
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoplasm Staging
KW  - Neoplasm, Residual
KW  - Ovarian Neoplasms
KW  - Prognosis
KW  - Remission Induction
KW  - Reoperation
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1097/00000421-199710000-00019
ER  -